CLS: Large order from ClearPoint Neuro - Redeye

Redeye is positive about the large SEK23m order from ClearPoint Neuro, as we believe it provides much-needed confidence in CLS’s accelerated commercial strategy within the Prism business. Furthermore, we view today’s announcement as supportive of our projected sales ramp-up and reiterate our base case valuation of the company.

Länk till analysen i sin helhet: https://www.redeye.se/research/1166000/cls-large-order-from-clearpoint-neuro?utm_source=finwire&utm_medium=RSS